OrthoPediatrics Corp (KIDS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.72 is considered Undervalued compared with the five-year average of -42.46. The fair price of OrthoPediatrics Corp (KIDS) is between 30.77 to 88.43 according to relative valuation method. Compared to the current price of 19.22 USD , OrthoPediatrics Corp By Undervalued By 37.54%.

Relative Value

Fair Zone

30.77-88.43

Current Price：19.22

37.54%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is OrthoPediatrics Corp (KIDS) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

OrthoPediatrics Corp (KIDS) has a current Price-to-Book (P/B) ratio of 1.26. Compared to its 3-year average P/B ratio of 1.86, the current P/B ratio is approximately -32.15% higher. Relative to its 5-year average P/B ratio of 2.91, the current P/B ratio is about -56.75% higher. OrthoPediatrics Corp (KIDS) has a Forward Free Cash Flow (FCF) yield of approximately -6.68%. Compared to its 3-year average FCF yield of -6.15%, the current FCF yield is approximately 8.75% lower. Relative to its 5-year average FCF yield of -4.62%, the current FCF yield is about 44.84% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for KIDS competitors is 3.30, providing a benchmark for relative valuation. OrthoPediatrics Corp Corp (KIDS.O) exhibits a P/S ratio of 1.72, which is -47.73% above the industry average. Given its robust revenue growth of 16.97%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of KIDS increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of KIDS in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is KIDS currently overvalued or undervalued?

What is OrthoPediatrics Corp (KIDS) fair value?

KIDS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of OrthoPediatrics Corp (KIDS) is between 30.77 to 88.43 according to relative valuation method.

How does KIDS's valuation metrics compare to the industry average?

The average P/S ratio for KIDS's competitors is 3.30, providing a benchmark for relative valuation. OrthoPediatrics Corp Corp (KIDS) exhibits a P/S ratio of 1.72, which is -47.73% above the industry average. Given its robust revenue growth of 16.97%, this premium appears unsustainable.

What is the current P/B ratio for OrthoPediatrics Corp (KIDS) as of Mar 03 2026?

As of Mar 03 2026, OrthoPediatrics Corp (KIDS) has a P/B ratio of 1.26. This indicates that the market values KIDS at 1.26 times its book value.

What is the current FCF Yield for OrthoPediatrics Corp (KIDS) as of Mar 03 2026?

As of Mar 03 2026, OrthoPediatrics Corp (KIDS) has a FCF Yield of -6.68%. This means that for every dollar of OrthoPediatrics Corp's market capitalization, the company generates -6.68 cents in free cash flow.

What is the current Forward P/E ratio for OrthoPediatrics Corp (KIDS) as of Mar 03 2026?

As of Mar 03 2026, OrthoPediatrics Corp (KIDS) has a Forward P/E ratio of -13.35. This means the market is willing to pay $-13.35 for every dollar of OrthoPediatrics Corp's expected earnings over the next 12 months.

What is the current Forward P/S ratio for OrthoPediatrics Corp (KIDS) as of Mar 03 2026?

As of Mar 03 2026, OrthoPediatrics Corp (KIDS) has a Forward P/S ratio of 1.72. This means the market is valuing KIDS at $1.72 for every dollar of expected revenue over the next 12 months.

KIDS Valuation